Xiangling Li

Title: **Innovations of Xiangling Li: Pioneering the Use of Chloroquine in Gel Formulations**

Introduction

Xiangling Li, a distinguished inventor based in Guangdong, China, has made significant contributions to the field of medicine with his innovative approaches to treating infections. With a portfolio of two patents, he stands at the forefront of research aimed at improving therapeutic delivery systems.

Latest Patents

Xiangling Li's latest patents include notable formulations involving chloroquine. One such patent focuses on a chloroquine gel and a preparation method and application thereof. This product is specifically designed for the prevention and treatment of external genitalia infections and flat warts. The formulation utilizes a chloroquine nanosphere which comprises a water-soluble nanosphere carrier along with chloroquine or its derivatives. The careful balance in the mass ratio of chloroquine or its derivative to the carrier, set between 1:3 and 1:5, enhances the effectiveness of the product. Significant aspects of this formulation include the use of a water-soluble chitosan, characterized by a deacetylation degree between 80% and 95%, and a molecular weight ranging from 3000 to 5000 g/mol. Additionally, chloroquine derivatives such as hydroxychloroquine, chloroquine phosphate, or chloroquine sulfate are integral to these innovative formulations.

Career Highlights

Throughout his career, Xiangling Li has collaborated with prominent companies in the biotech sector, notably Guangzhou Hybribio Medicine Technology Ltd. and Guangzhou Hybribio Biotech Ltd. His work within these organizations has played a pivotal role in advancing research in medicinal gel formulations.

Collaborations

Xiangling Li has worked alongside talented coworkers, including Longxu Xie and Manli Yuan. The collaborative efforts among these professionals have propelled their research forward, fostering an environment conducive to innovation and development in the field.

Conclusion

Xiangling Li exemplifies the innovative spirit within the research community. With his advancements in chloroquine formulations, he not only addresses pressing medical challenges but also inspires ongoing exploration in therapeutic solutions. His contributions underscore the importance of research and collaboration in creating impactful medical technologies.